This study investigated for the first time AMURA in the characterization of amyloid and tau pathology in AD, revealing their potential as imaging markers for a timely diagnosis relying on SVM classification and XAI-based interpretation of the outcomes. This evidence concerns the gene MAPT and Alzheimer disease.